Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
JCI Insight|August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous systemJonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.Cell Reports|July 28, 2021
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonizationChao Dai, Jonathan P Rennhack, Taylor E Arnoff, et al.Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical OutcomesJustin Hwang, Xiaolei Shi, Andrew Elliott, et al.Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2025
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancerSamuel P Pitzen, Amber N Rudenick, Yinjie Qiu, et al.European Urology Oncology|December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerJacob J Orme, Fadi Taza, Navonil De Sarkar, et al.Cell Reports|June 13, 2024
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinomaTalal El Zarif, Karl Semaan, Marc Eid, et al.Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.Pageof 4